Evaluation of anti-depressant activity of zinc and vitamin B6 as adjuvants to fluoxetine in an animal model of depression


  • Sunitha T. Department of Pharmacology, Government Medical College, Siddipet, Telangana, India
  • Prabhat G. Department of Pharmacology, Gandhi Medical College, Secunderabad, Telangana, India
  • Kiran Kishore Department of Clinical Pharmacology and Therapeutics, Nizams Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, India
  • Venu Madhavi L. Department of Clinical Pharmacology and Therapeutics, Nizams Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana, India




Animal model, Depression, Fluoxetine, Forced swim test, Vitamin B6, Zinc


Background: Depression is a significant public health problem. It is estimated by the World Health Organization that more than 300 million people suffer from depression globally. Micronutrient deficiencies have been constantly linked to depression. The currently used drugs in treatment of depression modulate the excitatory and/or the inhibitory neurotransmission pathways through different mechanisms. The aim of the present study was to compare the antidepressant effect of the micronutrients, zinc and vitamin B6, as adjuvants to Fluoxetine in Albino Wistar rats.

Methods: Eighteen albino wistar rats of 180-280grams of either sex were used in the study to evaluate the anti-depressant activity after approval from the Institutional Animal Ethics Committee. They were divided into three groups of six rats each (3 groups). Group 1 was control group which received only distilled water, group 2 was standard group which received fluoxetine and group 3 was test group which received zinc, vitamin B6 and fluoxetine. The anti-depressant activity was measured using the forced swimming test (FST) which works on the principles of behavioral despair. Data analysis was done using IBM SPSS software, version 25.0 and p value <0.05 was considered statistically significant.

Results: The rats of the standard and test groups had latency periods’ means of 268.83±30.16, 126.17±22.33 and 125.33±11.86 on 254.83±13.00, 118.67±8.16 and 127.17±6.68 seconds on days 1, 7 and 14 respectively (p <0.001) and the rats of the standard and test groups had despair periods’ means of 177.00±7.46, 95.17±10.65, 93.17±7.47and 167.17±14.82, 97.33±7.63 and 87.50±4.1 seconds on days 1, 7 and 14 respectively (p <0.001).

Conclusions: Supplementation of zinc and vitamin B6 to the standard treatment fluoxetine yielded better anti-depressant activity than fluoxetine alone in rats subjected to stress.


Depression. Available at: http://www.who.int/en/news-room/fact-sheets/detail/depression. Accessed on 25th October 2018.

Cornish S, Mehl-Madrona L. The role of vitamins and minerals in psychiatry. Integrative Medicine Insights. 2008 Jan;3.

Sandstead HH, Frederickson CJ, Penland JG. History of zinc as related to brain function. J Nutrition. 2000 Feb 1;130(2):496S-502S.

Mikkelsen K, Stojanovska L, Apostolopoulos V. The effects of vitamin B in depression. Current Med Chem. 2016 Nov 1;23(38):4317-37.

Takeda A, Hirate M, Tamano H, Oku N. Release of glutamate and GABA in the hippocampus under zinc deficiency. J Neurosci Res. 2003 May 15;72(4):537-42.

Mesripour A, Hajhashemi V, Kuchak A. Effect of concomitant administration of three different antidepressants with vitamin B6 on depression and obsessive compulsive disorder in mice models. Res Pharmaceutical Sci. 2017 Feb;12(1):46-52.

Martin SJ, Grimwood PD, Morris RG. Synaptic plasticity and memory: an evaluation of the hypothesis. Annual Rev Neurosci. 2000 Mar;23(1):649-711.

Porsolt RD, Le Pichon M, Jalfre ML. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977 Apr;266(5604):730-2.

Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Int Arch Pharmacodynamics Therapy. 1977 Oct;229(2):327-36.

Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003 Jul 18;301(5631):386-9.

Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S, et al. Brain-derived neurotrophic factor–5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry. 2006 Apr 15;59(8):673-80.

Jurowski K, Szewczyk B, Nowak G, Piekoszewski W. Biological consequences of zinc deficiency in the pathomechanisms of selected diseases. JBIC Journal of Biological Inorganic Chem. 2014 Oct 1;19(7):1069-79.

Szewczyk B, Kubera M, Nowak G. The role of zinc in neurodegenerative inflammatory pathways in depression. Progress Neuro-Psychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):693-701.

Maserejian NN, Hall SA, McKinlay JB. Low dietary or supplemental zinc is associated with depression symptoms among women, but not men, in a population-based epidemiological survey. J Affective Dis. 2012 Feb 1;136(3):781-8.

Wang J, Um P, Dickerman BA, Liu J. Zinc, Magnesium, Selenium and Depression: a review of the evidence, potential mechanisms and implications. Nutrients. 2018;10.

Huang EP. Metal ions and synaptic transmission: think zinc. Proceed National Acad Sci. 1997 Dec 9;94(25):13386-7.

Chen N, Moshaver A, Raymond LA. Differential Sensitivity of RecombinantN-Methyl-D-Aspartate Receptor Subtypes to Zinc Inhibition. Molecular Pharmacol. 1997 Jun 1;51(6):1015-23.

Kalappa BI, Anderson CT, Goldberg JM, Lippard SJ, Tzounopoulos T. AMPA receptor inhibition by synaptically released zinc. Proceed National Acad Sci. 2015 Dec 22;112(51):15749-54.

Marchetti C. Interaction of metal ions with neurotransmitter receptors and potential role in neurodiseases. Biometals. 2014 Dec 1;27(6):1097-113.

Gao HL, Zheng W, Xin N, Chi ZH, Wang ZY, Chen J, et al. Zinc deficiency reduces neurogenesis accompanied by neuronal apoptosis through caspase-dependent and-independent signaling pathways. Neurotoxicity research. 2009 Nov 1;16(4):416-25.

Pfaender S, Föhr K, Lutz AK, Putz S, Achberger K, Linta L, et al. Cellular zinc homeostasis contributes to neuronal differentiation in human induced pluripotent stem cells. Neural plasticity. 2016;1-5.

Takeda A, Tamano H, Ogawa T, Takada S, Ando M, Oku N, Watanabe M. Significance of serum glucocorticoid and chelatable zinc in depression and cognition in zinc deficiency. Behavioural Brain Res. 2012 Jan 1;226(1):259-64.

Jokinen J, Nordström P. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affective Dis. 2009 Jul 1;116(1-2):117-20.

Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008 Sep 1;31(9):464-8.




How to Cite

T., S., G., P., Kishore, K., & L., V. M. (2018). Evaluation of anti-depressant activity of zinc and vitamin B6 as adjuvants to fluoxetine in an animal model of depression. International Journal of Basic & Clinical Pharmacology, 7(12), 2359–2363. https://doi.org/10.18203/2319-2003.ijbcp20184846



Original Research Articles